Xianjun Tang

Sacituzumab tirumotecan (SKB264/MK-2870) in patients (pts) with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the phase III OptiTROP-Breast01 study.

Binghe Xu, Yongmei Yin, Ying Fan et al. · Journal of Clinical Oncology · 2024 · 45 citations

Medicine, Oncology, Pharmacology +17

Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial

Yongmei Yin, Ying Fan, Quchang Ouyang et al. · Nature Medicine · 2025 · 45 citations

Medicine, Oncology, Pharmacology +14

Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial

Tingting Che, Xiaochun Teng, Qun Huang et al. · Neuropsychiatric Disease and Treatment · 2018 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

miR-10b promoted melanoma progression through Wnt/β-catenin pathway by repressing ITCH expression

Shengqiang Wang, Yi Wu, Yan Xu et al. · Gene · 2019 · 24 citations

Life Sciences, Molecular Biology, Oncology +16

Unveiling the dynamics of antibiotic resistome, bacterial communities, and metals from the feces of patients in a typical hospital wastewater treatment system

Jing Bian, Hang Wang, Haojie Ding et al. · The Science of The Total Environment · 2022 · 21 citations

Life Sciences, Infectious Diseases, Microbiology +16